The company participated in a conference call with investors on August 4, 2026, at 11:00 AM IST.
The purpose of the call was to discuss the financial performance based on the Un-Audited Financial Results for the 1st quarter ended June 30, 2026 (Q1 FY26).
The meeting was conducted after the earnings announcement, specifically on the same day as the disclosure (August 4, 2026).
Management participants were not specifically named in the disclosure.
An audio recording of the conference call was made available at the provided link: https://ilshospitals.com/wp-content/uploads/2026/08/10044936.mp3
The recording has been uploaded to the company's website.
The company explicitly stated that "No unpublished price sensitive information was shared / discussed in the meeting."
Additional Notes Section
The disclosure represents a compliance filing under Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
No financial data or specific performance figures were disclosed in this announcement.
The document was digitally signed by Ankur Sharma, Company Secretary and Compliance Officer (Membership Number A31833).
